TotalMarketCap

Corcept Therapeutics

CORTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.814 B

$118.54 -0.89%

Close of 9 Oct 2026

As of 9 Oct 2026, Corcept Therapeutics (CORT) has a market capitalization of $12.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$761.4M

#1672 by revenue

Earnings

$99.7M

#1307 by earnings

Shares outstanding

108,098,397

Latest filing cover page

P/E ratio

128.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #26Jazz PharmaceuticalsJAZZ$14.4B
  2. #27Summit TherapeuticsSMMT$13.7B
  3. #28Corcept TherapeuticsCORT$12.8B
  4. #29BridgeBio PharmaBBIO$12.7B
  5. #30Elanco Animal HealthELAN$11.3B

What if Corcept Therapeutics were worth as much as…

Open the what-if tool →

Gold $29.1T

$268,846.32

Per share 2,268× higher

Bitcoin $1.66T

$15,361.75

Per share 130× higher

Nvidia $5.55T

$51,384.37

Per share 433× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Corcept Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.